$PBH
Prestige Consumer Healthcare Inc.

2024 Q3 Form 10-Q Financial Statement

#000129594724000025 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $283.8M $267.1M
YoY Change -0.88% -4.36%
Cost Of Revenue $126.4M $121.1M
YoY Change 0.08% -2.82%
Gross Profit $157.4M $146.0M
YoY Change -1.65% -5.59%
Gross Profit Margin 55.46% 54.66%
Selling, General & Admin $67.48M $68.28M
YoY Change 2.08% 6.82%
% of Gross Profit 42.87% 46.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.929M $8.124M
YoY Change 3.74% 7.7%
% of Gross Profit 5.04% 5.56%
Operating Expenses $73.04M $73.98M
YoY Change 1.77% 6.47%
Operating Profit $84.34M $72.05M
YoY Change -4.43% -15.43%
Interest Expense -$12.28M -$13.14M
YoY Change -30.25% -25.86%
% of Operating Profit -14.56% -18.23%
Other Income/Expense, Net -$395.0K -$496.0K
YoY Change 72.49% -140.06%
Pretax Income $71.66M $58.41M
YoY Change 1.77% -14.99%
Income Tax $17.29M $9.345M
% Of Pretax Income 24.12% 16.0%
Net Earnings $54.38M $49.07M
YoY Change 1.53% -7.9%
Net Earnings / Revenue 19.16% 18.37%
Basic Earnings Per Share $1.10 $0.98
Diluted Earnings Per Share $1.09 $0.98
COMMON SHARES
Basic Shares Outstanding 49.56M shares 49.92M shares
Diluted Shares Outstanding 50.00M shares 50.27M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $51.54M $34.26M
YoY Change -14.2% -37.24%
Cash & Equivalents $51.54M $34.26M
Short-Term Investments
Other Short-Term Assets $9.396M $10.75M
YoY Change 11.96% 14.62%
Inventory $156.2M $152.0M
Prepaid Expenses
Receivables $163.5M $171.7M
Other Receivables $0.00 $0.00
Total Short-Term Assets $380.7M $368.7M
YoY Change -1.93% -5.88%
LONG-TERM ASSETS
Property, Plant & Equipment $74.92M $75.41M
YoY Change 5.97% 7.76%
Goodwill $529.2M $528.4M
YoY Change 0.45% 0.19%
Intangibles $2.317B $2.318B
YoY Change -0.5% -0.78%
Long-Term Investments
YoY Change
Other Assets $6.727M $6.232M
YoY Change 74.18% 90.76%
Total Long-Term Assets $2.936B $2.939B
YoY Change -0.29% -0.51%
TOTAL ASSETS
Total Short-Term Assets $380.7M $368.7M
Total Long-Term Assets $2.936B $2.939B
Total Assets $3.317B $3.308B
YoY Change -0.48% -1.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.17M $39.56M
YoY Change -29.76% -31.64%
Accrued Expenses $75.54M $73.58M
YoY Change 1.69% -4.19%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $91.00K $795.0K
YoY Change -96.84% -72.15%
Total Short-Term Liabilities $106.9M $114.1M
YoY Change -17.58% -22.51%
LONG-TERM LIABILITIES
Long-Term Debt $1.060B $1.100B
YoY Change -16.86% -17.29%
Other Long-Term Liabilities $5.124M $5.138M
YoY Change -42.4% -37.21%
Total Long-Term Liabilities $1.065B $1.105B
YoY Change -17.04% -17.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $106.9M $114.1M
Total Long-Term Liabilities $1.065B $1.105B
Total Liabilities $1.585B $1.627B
YoY Change -11.79% -12.79%
SHAREHOLDERS EQUITY
Retained Earnings $1.445B $1.390B
YoY Change 16.63% 17.31%
Common Stock $557.0K $557.0K
YoY Change 0.91% 0.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.732B $1.681B
YoY Change
Total Liabilities & Shareholders Equity $3.317B $3.308B
YoY Change -0.48% -1.14%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $54.38M $49.07M
YoY Change 1.53% -7.9%
Depreciation, Depletion And Amortization $7.929M $8.124M
YoY Change 3.74% 7.7%
Cash From Operating Activities $69.80M $54.78M
YoY Change 11.75% 13.91%
INVESTING ACTIVITIES
Capital Expenditures $2.027M $1.152M
YoY Change -30.91% -22.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $978.0K
YoY Change -125.74%
Cash From Investing Activities -$2.027M -$2.130M
YoY Change -30.91% -191.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -51.20M -$65.52M
YoY Change -4.39% 20.94%
NET CHANGE
Cash From Operating Activities 69.80M $54.78M
Cash From Investing Activities -2.027M -$2.130M
Cash From Financing Activities -51.20M -$65.52M
Net Change In Cash 16.57M -$12.21M
YoY Change 177.28% 212.43%
FREE CASH FLOW
Cash From Operating Activities $69.80M $54.78M
Capital Expenditures $2.027M $1.152M
Free Cash Flow $67.77M $53.62M
YoY Change 13.85% 15.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
267142000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
279309000 usd
CY2024Q2 pbh Cost Of Sales Exclusive Of Depreciation
CostOfSalesExclusiveOfDepreciation
118697000 usd
CY2023Q2 pbh Cost Of Sales Exclusive Of Depreciation
CostOfSalesExclusiveOfDepreciation
122654000 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
2423000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
1982000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
121120000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
124636000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
146022000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
154673000 usd
CY2024Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
39365000 usd
CY2023Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
36231000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28910000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27687000 usd
CY2024Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
5701000 usd
CY2023Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
5561000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
73976000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
69479000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
72046000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
85194000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-496000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1238000 usd
CY2024Q2 pbh Total Other Income Expense
TotalOtherIncomeExpense
-13633000 usd
CY2023Q2 pbh Total Other Income Expense
TotalOtherIncomeExpense
-16481000 usd
CY2024Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
58413000 usd
CY2023Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
68713000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9345000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15437000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
49068000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
53276000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.98
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.98
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.06
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49886000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49767000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50267000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50196000 shares
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3160000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-646000 usd
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
720000 usd
CY2023Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
699000 usd
CY2024Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1975000 usd
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7028000 usd
CY2024Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5801000 usd
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5508000 usd
CY2024Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25976000 usd
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25000000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-65522000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-54179000 usd
CY2024Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
663000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-140000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12213000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3909000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46469000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58489000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34256000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54580000 usd
CY2024Q2 us-gaap Interest Paid Net
InterestPaidNet
13670000 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
17582000 usd
CY2024Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
3661000 usd
CY2023Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
11964000 usd
CY2024Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
13137000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
17719000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3160000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-646000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
52228000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
52630000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34256000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46469000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
18684000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
16377000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
171695000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
176775000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
152040000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
138717000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10750000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13082000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
368741000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
375043000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75409000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76507000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9997000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11285000 usd
CY2024Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
877000 usd
CY2024Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1541000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
528443000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
527733000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2317817000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2320583000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6232000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5725000 usd
CY2024Q2 us-gaap Assets
Assets
3307516000 usd
CY2024Q1 us-gaap Assets
Assets
3318417000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
39556000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
38979000 usd
CY2024Q2 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
15248000 usd
CY2024Q1 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
15763000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3654000 usd
CY2024Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div>The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.  Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates. Our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4658000 usd
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
795000 usd
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1494000 usd
CY2024Q2 pbh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
54862000 usd
CY2024Q1 pbh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
56154000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
114115000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
117048000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
1091207000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
1125804000 usd
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
409085000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
403596000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7055000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7528000 usd
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
149000 usd
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
172000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5138000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9185000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
1626749000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
1663333000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55717000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55501000 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
557000 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
555000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
572846000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
567448000 usd
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6164000 shares
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5680000 shares
CY2024Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
251566000 usd
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
219621000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-31335000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-34495000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1390265000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1341197000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1680767000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1655084000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3307516000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3318417000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1655084000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3425000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1975000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
31945000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
49068000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3160000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1680767000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1447084000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4146000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7028000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
30593000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
53276000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-646000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1480295000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
49068000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
53276000 usd
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8124000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7543000 usd
CY2024Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2024Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
612000 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4272000 usd
CY2024Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
454000 usd
CY2023Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
983000 usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3425000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
4146000 usd
CY2024Q2 pbh Additions To Operating Lease Right Of Use Assets
AdditionsToOperatingLeaseRightOfUseAssets
1706000 usd
CY2023Q2 pbh Additions To Operating Lease Right Of Use Assets
AdditionsToOperatingLeaseRightOfUseAssets
1244000 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6368000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5632000 usd
CY2024Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13048000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7711000 usd
CY2024Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2359000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5181000 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
591000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5599000 usd
CY2024Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2061000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-8519000 usd
CY2024Q2 pbh Increase Decrease In Operating Leases Liabilities
IncreaseDecreaseInOperatingLeasesLiabilities
-1883000 usd
CY2023Q2 pbh Increase Decrease In Operating Leases Liabilities
IncreaseDecreaseInOperatingLeasesLiabilities
-1745000 usd
CY2024Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
944000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
254000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
54776000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
48087000 usd
CY2024Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1152000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1477000 usd
CY2024Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
978000 usd
CY2023Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-3800000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2130000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2323000 usd
CY2024Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
35000000 usd
CY2023Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
30000000 usd
CY2024Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
20124000 usd
CY2024Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
19210000 usd
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1253000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
636000 usd
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
130663000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
118871000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
152040000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
138717000 usd
CY2024Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4600000 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4700000 usd
CY2024Q1 us-gaap Goodwill Gross
GoodwillGross
741836000 usd
CY2024Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
214103000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
527733000 usd
CY2024Q2 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
309000 usd
CY2024Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
401000 usd
CY2024Q2 us-gaap Goodwill Gross
GoodwillGross
742546000 usd
CY2024Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
214103000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
528443000 usd
CY2024Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
2578420000 usd
CY2024Q2 pbh Intangible Assets Translation Adjustments Gain Loss
IntangibleAssetsTranslationAdjustmentsGainLoss
2277000 usd
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
2580697000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
257837000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4954000 usd
CY2024Q2 pbh Finite Lived Intangible Assets Accumulated Amortization Translation Adjustments Gain Loss
FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss
-89000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
262880000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2317817000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5000000.0 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5000000.0 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
13204000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
16213000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
14621000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
12285000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
12285000 usd
CY2024Q2 pbh Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
80238000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
148846000 usd
CY2024Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
665000 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
665000 usd
CY2024Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
9000 usd
CY2023Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
30000 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1704000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1624000 usd
CY2024Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
32000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
33000 usd
CY2024Q2 us-gaap Variable Lease Cost
VariableLeaseCost
16423000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
16456000 usd
CY2024Q2 us-gaap Lease Cost
LeaseCost
18833000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
18808000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3348000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
779000 usd
CY2024Q2 pbh Operating And Finance Lease Liability Payments Remainder Of Fiscal Year
OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
4127000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2750000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
96000 usd
CY2024Q2 pbh Operating And Finance Lease Liability Payments Due Year One
OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne
2846000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2214000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
80000 usd
CY2024Q2 pbh Operating And Finance Lease Liability Payments Due Year Two
OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo
2294000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1733000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
0 usd
CY2024Q2 pbh Operating And Finance Lease Liability Payments Due Year Three
OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree
1733000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
374000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0 usd
CY2024Q2 pbh Operating And Finance Lease Liability Payments Due Year Four
OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour
374000 usd
CY2024Q2 pbh Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
1597000 usd
CY2024Q2 pbh Finance Lease Liability To Be Paid Due After Year Four
FinanceLeaseLiabilityToBePaidDueAfterYearFour
0 usd
CY2024Q2 pbh Operating And Finance Lease Liability Payments Due After Year Four
OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour
1597000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
12016000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
955000 usd
CY2024Q2 pbh Operating And Finance Lease Liability Payment Due
OperatingAndFinanceLeaseLiabilityPaymentDue
12971000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1307000 usd
CY2024Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
11000 usd
CY2024Q2 pbh Operating And Finance Lease Liability Undiscounted Excess Amount
OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount
1318000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
10709000 usd
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
944000 usd
CY2024Q2 pbh Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
11653000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M10D
CY2024Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y10M2D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0477
CY2024Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0289
CY2024Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
30630000 usd
CY2024Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
24053000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6216000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12221000 usd
CY2024Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1662000 usd
CY2024Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1309000 usd
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
189000 usd
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2569000 usd
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6683000 usd
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5046000 usd
CY2024Q2 pbh Accrued Production Costs Current
AccruedProductionCostsCurrent
3598000 usd
CY2024Q1 pbh Accrued Production Costs Current
AccruedProductionCostsCurrent
4166000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5884000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6790000 usd
CY2024Q2 pbh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
54862000 usd
CY2024Q1 pbh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
56154000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1100000000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1135000000 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
8793000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
9196000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
1091207000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
1125804000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
400000000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
100000000 usd
CY2024Q2 pbh Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
600000000 usd
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1100000000 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000.0 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000.0 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q2 pbh Voting Rights Number Of Votes Per Common Share Owned
VotingRightsNumberOfVotesPerCommonShareOwned
1 vote
CY2024Q2 us-gaap Dividends Common Stock
DividendsCommonStock
0 usd
CY2024Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
300000000 usd
CY2024 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
0 usd
CY2024Q2 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
49068000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
53276000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49886000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49767000 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
381000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
429000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50267000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50196000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.98
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.98
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.06
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3425000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4146000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
438000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
406000 usd
CY2024Q2 pbh Share Based Compensation Arrangement By Share Based Payment Award Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
11150000 usd
CY2023Q2 pbh Share Based Compensation Arrangement By Share Based Payment Award Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
11226000 usd
CY2024Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1975000 usd
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7028000 usd
CY2024Q2 pbh Effective Income Tax Rate Reconciliation Deduction Restricted Stock Issuances And Stock Options Amount
EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
667000 usd
CY2023Q2 pbh Effective Income Tax Rate Reconciliation Deduction Restricted Stock Issuances And Stock Options Amount
EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
876000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4500000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M24D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1081000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
43.96
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
128100 shares
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
61.73
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
172900 shares
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
40.64
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
19300 shares
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
54.86
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1700 shares
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
54.47
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1015200 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.54
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13369000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
700100 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
42.70
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y4M24D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
11714000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
728000.0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
48.30
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
109700 shares
CY2024Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
69.94
CY2024Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
38300 shares
CY2024Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
51.61
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
9900 shares
CY2024Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
59.11
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
789500 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
51.01
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M6D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
14207000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
551900 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
45.45
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y7M6D
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
12915000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
500000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.160
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.225
CY2024Q2 pbh Number Of Third Party Manufacturers
NumberOfThirdPartyManufacturers
113 manufacturer
CY2023Q2 pbh Number Of Third Party Manufacturers
NumberOfThirdPartyManufacturers
135 manufacturer
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
267142000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
121120000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
146022000 usd
CY2024Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
39365000 usd
CY2024Q2 pbh Contribution Margin
ContributionMargin
106657000 usd
CY2024Q2 pbh General And Administrative And Depreciation And Amortization Expense
GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
34611000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
72046000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
279309000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
124636000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
154673000 usd
CY2023Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
36231000 usd
CY2023Q2 pbh Contribution Margin
ContributionMargin
118442000 usd
CY2023Q2 pbh General And Administrative And Depreciation And Amortization Expense
GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
33248000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
85194000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
267142000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
279309000 usd

Files In Submission

Name View Source Status
0001295947-24-000025-index-headers.html Edgar Link pending
0001295947-24-000025-index.html Edgar Link pending
0001295947-24-000025.txt Edgar Link pending
0001295947-24-000025-xbrl.zip Edgar Link pending
exhibit3112024-06x30.htm Edgar Link pending
exhibit312-certificateofam.htm Edgar Link pending
exhibit3122024-06x30.htm Edgar Link pending
exhibit3212024-06x30.htm Edgar Link pending
exhibit3222024-06x30.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pbh-20240630.htm Edgar Link pending
pbh-20240630.xsd Edgar Link pending
pbh-20240630_g1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
pbh-20240630_def.xml Edgar Link unprocessable
pbh-20240630_htm.xml Edgar Link completed
pbh-20240630_lab.xml Edgar Link unprocessable
pbh-20240630_pre.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pbh-20240630_cal.xml Edgar Link unprocessable